Lobbying Relationship

Client

Allergan USA, Inc.

More records

Lobbying firm

J P Ford Strategies, LLC

More records

  • Proposals to maintain and strengthen intellectual property protections to incentivize research and development of novel, new life-saving therapies to meet unmet medical needs; proposals to modify the Hatch Waxman Act and the America Invents Act.

Duration: to

General Issues: Copyright/Patent/Trademark, Pharmacy

Spending: about $30,000 (But it's complicated. Here's why.)

Agencies lobbied since 2018: House of Representatives, U.S. Senate

Affiliated organizations: Allergan, Inc.

Related Foreign Entities: Allergan plc (Coolock, Dublin D17 E400, IRL); contribution to lobbying: $0; ownership 100%

Lobbyists

Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.

Lobbyist Covered positions?
John Ford Counsel/Senior Counsel, House Energy and Commerce Committee

Disclosures Filed

Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.

Termination
Q3 Report
Q2 Report
Registration

Source: Clerk of the U.S. House of Representatives and Secretary of the Senate

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page